2021
DOI: 10.3390/diagnostics11071194
|View full text |Cite
|
Sign up to set email alerts
|

State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma

Abstract: The most common liver malignancy is hepatocellular carcinoma (HCC), which is also associated with high mortality. Often HCC develops in a chronic liver disease setting, and early diagnosis as well as accurate screening of high-risk patients is crucial for appropriate and effective management of these patients. While imaging characteristics of HCC are well-defined in the diagnostic phase, challenging cases still occur, and current prognostic and predictive models are limited in their accuracy. Radiomics and mac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 89 publications
0
12
0
Order By: Relevance
“…The research on Artificial Intelligence (AI) has greatly expanded in the last few years. The application of AI in HCC imaging has demonstrated promising results regarding differentiation from other lesions, prediction of grading and microvascular invasion, identification of specific molecular profile, prediction of response to treatment or post-operative recurrence, and guidance on treatment selection [ 178 , 179 , 180 ]. However, validation of these results in larger, prospective, multicenter studies is required in the years to come and before AI proves its clinical utility.…”
Section: Artificial Intelligencementioning
confidence: 99%
“…The research on Artificial Intelligence (AI) has greatly expanded in the last few years. The application of AI in HCC imaging has demonstrated promising results regarding differentiation from other lesions, prediction of grading and microvascular invasion, identification of specific molecular profile, prediction of response to treatment or post-operative recurrence, and guidance on treatment selection [ 178 , 179 , 180 ]. However, validation of these results in larger, prospective, multicenter studies is required in the years to come and before AI proves its clinical utility.…”
Section: Artificial Intelligencementioning
confidence: 99%
“…Each item contributes to a final percentage score for the paper, allowing for a quantitative assessment of methodological quality. The value of the RQS is also confirmed by its use across various topics in the recent literature [ 18 20 ]. An additional advantage of the RQS is the possibility to use its final score to perform statistical analyses with other variables.…”
Section: Introductionmentioning
confidence: 67%
“…Detailed information on deep learning and convolutional neural network is available in another focused review [ 118 ]. Regarding HCC imaging, deep learning has been studied not only for diagnosis but also for other fields such as segmentation, pathologic grading, and prediction of treatment response and prognosis [ 120 ]. In this article, we briefly introduce several studies on deep learning for the detection and diagnosis of HCC.…”
Section: Future Aspects For Hcc Surveillance and Diagnosismentioning
confidence: 99%